Replies to post #165 on Oncolytics Biotech Inc. (ONCY)

[onco_investor]

REO-021 PII Trial Update San Antonio Nightly News

This SCC Lung cancer trial was just started in April of this year so still in the early stages but it is hard not to get a good feeling from seeing results like these publicized as it should help the enrollment pace. Coverage from two of the major news stations in San Antonio, Texas.

First we have FOX 29 News in San Antonio, Texas

http://www.foxsanantonio.com/newsroom/top_stories/videos/vid_2266.shtml

and then we have...

KENS News 5 San Antonio, Texas

http://www.kens5.com/news/health/SA-lung-cancer-patients-are-helping-test-a-new-novel-approach-to-attacking-the-killer-disease-91621924.html


Thanks for RJC and Matdu for the digging and as has been pointed out by a Bridger the dosage of the Reolysin vial in this new Phase II SCLC trial shows a 50% increase in active viral particles/ml to 4.5x10p10 TCID.